Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Shanghai Pharmaceuticals Holding Co ( (HK:2607) ) has provided an update.
Shanghai Pharmaceuticals Holding Co., Ltd. has established implementation rules for its Audit Committee to strengthen the decision-making function of its Board of Directors and ensure effective supervision over management. The Audit Committee is tasked with overseeing the relationship with external auditors, reviewing financial information, and supervising the company’s financial reporting, risk management, and internal control systems. This move is expected to enhance the company’s corporate governance and ensure diligent financial oversight.
The most recent analyst rating on (HK:2607) stock is a Buy with a HK$13.00 price target. To see the full list of analyst forecasts on Shanghai Pharmaceuticals Holding Co stock, see the HK:2607 Stock Forecast page.
More about Shanghai Pharmaceuticals Holding Co
Shanghai Pharmaceuticals Holding Co., Ltd. operates in the pharmaceutical industry, focusing on the development, manufacturing, and distribution of pharmaceutical products. The company is committed to optimizing its corporate governance structure and enhancing its decision-making processes.
Average Trading Volume: 3,061,652
Technical Sentiment Signal: Buy
Current Market Cap: HK$66.15B
See more insights into 2607 stock on TipRanks’ Stock Analysis page.